HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bruce E Johnson Selected Research

Aftercare (After-Treatment)

9/2009Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
11/2005The pulmonary status of patients with limited-stage small cell lung cancer 15 years after treatment with chemotherapy and chest irradiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bruce E Johnson Research Topics

Disease

102Neoplasms (Cancer)
05/2024 - 03/2002
92Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2024 - 06/2002
39Lung Neoplasms (Lung Cancer)
02/2024 - 05/2004
16Adenocarcinoma of Lung
01/2023 - 06/2004
14Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2019 - 02/2002
12Neoplasm Metastasis (Metastasis)
01/2019 - 11/2002
11Disease Progression
10/2017 - 06/2002
7Brain Neoplasms (Brain Tumor)
01/2019 - 10/2005
7Malignant Mesothelioma
01/2018 - 09/2002
5Adenocarcinoma
12/2021 - 05/2004
4Melanoma (Melanoma, Malignant)
02/2024 - 07/2016
4Carcinogenesis
12/2023 - 10/2003
4Carcinoma (Carcinomatosis)
12/2023 - 07/2003
4Exanthema (Rash)
11/2013 - 05/2004
3Breast Neoplasms (Breast Cancer)
05/2024 - 07/2006
3Diarrhea
02/2024 - 09/2005
3Nausea
02/2024 - 05/2004
3Osteoporosis
09/2012 - 09/2007
2Vomiting
02/2024 - 10/2017
2Fatigue
02/2024 - 11/2013
2Neuroblastoma
01/2024 - 02/2015
2Dyspnea (Shortness of Breath)
12/2023 - 11/2013
2Aneuploidy (Aneuploid)
11/2023 - 11/2023
2Pneumonia (Pneumonitis)
01/2023 - 05/2008
2Colonic Neoplasms (Colon Cancer)
01/2022 - 07/2005
2Mesothelioma
01/2018 - 08/2008
2Leukopenia
01/2018 - 07/2010
2Circulating Neoplastic Cells
12/2016 - 03/2016
2Carcinoid Tumor (Carcinoid)
11/2014 - 05/2004
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2013 - 06/2013
2Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar)
05/2007 - 10/2004
1Skin Neoplasms (Skin Cancer)
02/2024
1Inflammation (Inflammations)
12/2023

Drug/Important Bio-Agent (IBA)

45ErbB Receptors (EGF Receptor)IBA
01/2023 - 09/2002
35Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2021 - 05/2005
28Gefitinib (Iressa)FDA Link
04/2016 - 05/2004
22Tyrosine Kinase InhibitorsIBA
03/2023 - 05/2005
16Biomarkers (Surrogate Marker)IBA
12/2023 - 07/2006
11DNA (Deoxyribonucleic Acid)IBA
05/2024 - 02/2006
9Immune Checkpoint InhibitorsIBA
01/2024 - 11/2018
9Paclitaxel (Taxol)FDA LinkGeneric
06/2013 - 06/2002
8vandetanib (ZD6474)IBA
04/2016 - 09/2007
8Phosphotransferases (Kinase)IBA
08/2015 - 06/2004
8Carboplatin (JM8)FDA LinkGeneric
06/2013 - 05/2003
7Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2010 - 10/2004
6Proteins (Proteins, Gene)FDA Link
12/2023 - 07/2003
6RNA (Ribonucleic Acid)IBA
11/2023 - 11/2018
5Docetaxel (Taxotere)FDA Link
04/2016 - 05/2003
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2016 - 05/2005
4atezolizumabIBA
12/2023 - 10/2022
4AntibodiesIBA
01/2022 - 11/2008
4Anaplastic Lymphoma KinaseIBA
03/2020 - 10/2013
4Cisplatin (Platino)FDA LinkGeneric
01/2018 - 06/2002
4PlatinumIBA
04/2016 - 06/2013
4Bevacizumab (Avastin)FDA Link
09/2014 - 08/2008
4Cetuximab (Erbitux)FDA Link
11/2013 - 08/2005
3NucleotidesIBA
05/2024 - 09/2012
3binimetinibIBA
02/2024 - 03/2022
3encorafenibIBA
02/2024 - 03/2022
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2023 - 05/2007
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2023 - 02/2002
3CrizotinibIBA
03/2020 - 03/2017
3human ERBB2 proteinIBA
11/2017 - 02/2015
3dabrafenibIBA
10/2017 - 01/2016
3Monoclonal AntibodiesIBA
11/2013 - 07/2006
3Imatinib Mesylate (Gleevec)FDA Link
05/2004 - 08/2003
2Tumor Biomarkers (Tumor Markers)IBA
12/2023 - 03/2023
2DNA Transposable Elements (Element, IS)IBA
12/2023 - 03/2023
2InterleukinsIBA
12/2023 - 08/2005
2durvalumabIBA
11/2023 - 01/2023
2Small Cytoplasmic RNAIBA
01/2020 - 11/2018
2GemcitabineFDA Link
01/2018 - 06/2013
2trametinibIBA
10/2017 - 07/2016
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2017 - 11/2013
2Mitogen-Activated Protein KinasesIBA
07/2016 - 05/2007
2Discoidin Domain Receptor 2IBA
11/2013 - 06/2011
2Dasatinib (BMS 354825)FDA Link
11/2013 - 06/2011
2Formaldehyde (Formol)FDA Link
12/2012 - 02/2006
2ParaffinIBA
12/2012 - 02/2006
2EverolimusFDA Link
10/2012 - 08/2007
2Estrogens (Estrogen)FDA Link
03/2011 - 02/2010
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
05/2009 - 05/2009
2LigandsIBA
11/2008 - 11/2005
2pertuzumabIBA
10/2007 - 07/2006
2Zoledronic Acid (Zometa)FDA Link
10/2007 - 09/2007
2Ectopic HormonesIBA
07/2006 - 02/2006
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2004 - 10/2003
1Hormones (Hormone)IBA
05/2024
1Adrenergic Agents (Adrenergic Drugs)IBA
01/2024
1pembrolizumabIBA
12/2023
1canakinumabFDA Link
12/2023

Therapy/Procedure

72Therapeutics
02/2024 - 03/2002
31Drug Therapy (Chemotherapy)
12/2023 - 03/2002
6Radiotherapy
11/2018 - 06/2002
4Precision Medicine
10/2022 - 01/2018
3Immunotherapy
11/2023 - 11/2018
3Adjuvant Chemotherapy
09/2012 - 10/2003
2Combination Drug Therapy (Combination Chemotherapy)
10/2013 - 08/2013
2Aftercare (After-Treatment)
09/2009 - 11/2005
2Pneumonectomy (Lung Volume Reduction)
08/2009 - 02/2009